| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ACHILLION PHARMACEUTICALS IN | 929,290 | 7,527,000 | 0.49% | ||
| 52 | AKEBIA THERAPEUTICS INC | 809,096 | 7,295,000 | 0.47% | ||
| 53 | DYNAVAX TECHNOLOGIES CORP | 16,000 | 7,180,000 | 0.46% | Put | |
| 54 | NEPTUNE TECHNOLOGIES BIORESO | 6,750,444 | 7,155,000 | 0.46% | ||
| 55 | Agile Therapeutics, Inc. | 1,020,011 | 7,120,000 | 0.46% | ||
| 56 | AGENUS INC | 900,000 | 6,462,000 | 0.42% | ||
| 57 | CAPITAL SR LIVING CORP COM | 375,306 | 6,305,000 | 0.41% | ||
| 58 | ARROWHEAD PHARMACEUTICALS IN | 847,458 | 6,228,000 | 0.40% | ||
| 59 | CLOVIS ONCOLOGY INC | 171,500 | 6,183,000 | 0.40% | ||
| 60 | XENON PHARMACEUTICALS INC | 762,800 | 6,179,000 | 0.40% | ||
| 61 | SUPERNUS PHARMACEUTICALS INC | 244,550 | 6,048,000 | 0.39% | ||
| 62 | HISTOGENICS CORP | 1,777,777 | 5,706,000 | 0.37% | ||
| 63 | ASSEMBLY BIOSCIENCES INC | 777,669 | 5,606,000 | 0.36% | ||
| 64 | CASCADIAN THERAPEUTICS INC | 3,414,121 | 5,599,000 | 0.36% | ||
| 65 | PROTEOSTASIS THERAPEUTICS IN COM | 344,550 | 5,372,000 | 0.35% | ||
| 66 | ADMA BIOLOGICS, INC. | 734,793 | 5,327,000 | 0.34% | ||
| 67 | ONCOBIOLOGICS INC | 1,248,990 | 5,308,000 | 0.34% | ||
| 68 | AMARIN CORP PLC | 1,622,280 | 5,175,000 | 0.33% | ||
| 69 | SELECTA BIOSCIENCES INC | 348,150 | 4,961,000 | 0.32% | ||
| 70 | NEURODERM LTD | 264,114 | 4,883,000 | 0.32% | ||
| 71 | ANTHERA PHARMACEUTICALS I | 1,459,627 | 4,598,000 | 0.30% | ||
| 72 | CELLECTIS S A | 179,506 | 4,323,000 | 0.28% | ||
| 73 | CEMPRA INC | 175,503 | 4,247,000 | 0.27% | ||
| 74 | APPLIED GENETIC TECHNOL CORP | 426,048 | 4,167,000 | 0.27% | ||
| 75 | ABEONA THERAPEUTICS SHARES CW-19 | 1,259,636 | 4,093,000 | 0.26% | ||
| 76 | BEIGENE LTD | 132,057 | 4,069,000 | 0.26% | ||
| 77 | MYLAN N V | 94,711 | 3,610,000 | 0.23% | ||
| 78 | INNOCOLL HLDGS PLC | 547,792 | 3,221,000 | 0.21% | ||
| 79 | AVEO PHARMACEUTICALS INC | 3,108,808 | 2,766,000 | 0.18% | ||
| 80 | OPHTHOTECH CORP | 600,000 | 2,740,000 | 0.18% | Call | |
| 81 | APTEVO THERAPEUTICS INC | 988,133 | 2,530,000 | 0.16% | ||
| 82 | Proteon Therapeutics Inc | 269,005 | 2,510,000 | 0.16% | ||
| 83 | MGC DIAGNOSTICS CORP | 329,733 | 2,275,000 | 0.15% | ||
| 84 | NEOS THERAPEUTICS INC COM | 330,593 | 2,175,000 | 0.14% | ||
| 85 | IGNYTA INC COM | 339,727 | 2,137,000 | 0.14% | ||
| 86 | ACADIA PHARMACEUTICALS INC COM | 65,240 | 2,075,000 | 0.13% | ||
| 87 | AFFIMED N V COM | 734,301 | 2,041,000 | 0.13% | ||
| 88 | ARNO THERAPEUTICS SHARES | 4,177,577 | 1,963,000 | 0.13% | ||
| 89 | ABBOTT LABS | 46,019 | 1,946,000 | 0.13% | ||
| 90 | EIGER BIOPHARMACEUTICALS INC | 129,920 | 1,739,000 | 0.11% | ||
| 91 | CHINA BIOLOGIC PRODS INC | 13,695 | 1,705,000 | 0.11% | ||
| 92 | BIO RAD LABS INC | 10,000 | 1,638,000 | 0.11% | ||
| 93 | MEDGENICS INC | 293,460 | 1,635,000 | 0.11% | ||
| 94 | Vocera Communications Inc | 94,236 | 1,593,000 | 0.10% | ||
| 95 | ALLIQUA BIOMEDICAL INC | 1,921,951 | 1,537,000 | 0.10% | ||
| 96 | VERICEL CORP | 544,996 | 1,526,000 | 0.10% | ||
| 97 | NEVRO CORP COM | 11,746 | 1,226,000 | 0.08% | ||
| 98 | Nivalis Therapeutics Inc | 122,275 | 994,000 | 0.06% | ||
| 99 | BRAINSTORM CELL THERAPEUTICS INC SHARES (OLD) | 400,000 | 964,000 | 0.06% | ||
| 100 | ANTARES PHARMA INC | 0 | 912,000 | 0.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001019056-16-001648, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
